Evidence map›Paper›PMID 41605542›Full record

Trial reportBMJ (Clinical research ed.)2026

Reliability of urological telesurgery compared with local surgery: multicentre randomised controlled trial.

Ye Wang, Dan Xia, Wanhai Xu, Mulati Rexiati, Wuyi Zhao, Qingbo Huang, Taoping Shi, Baojun Wang, Shuo Wang, Sheng Tai and 25 more

Abstract readComparative StudyEquivalence TrialMulticenter Study
In one paragraph

Trial report in BMJ (Clinical research ed.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors.

Ye WangDepartment of Urology, Chinese PLA General Hospital, Beijing, China.ORCID https://orcid.org/0000-0002-5675-2733
Dan XiaDepartment of Urology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Wanhai XuDepartment of Urology, Harbin Medical University Cancer Hospital, Harbin, China.
Mulati RexiatiDepartment of Urology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
Wuyi ZhaoShenzhen Edge Medical Co, Shenzhen, China.
Qingbo HuangDepartment of Urology, Chinese PLA General Hospital, Beijing, China.
Taoping ShiDepartment of Urology, Chinese PLA General Hospital, Beijing, China.
Baojun WangDepartment of Urology, Chinese PLA General Hospital, Beijing, China.
Shuo WangDepartment of Urology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Sheng TaiDepartment of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Bingzhang QiaoDepartment of Urology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
Yubai ZhangDepartment of Urology, Harbin Medical University Cancer Hospital, Harbin, China xzhang@foxmail.com.
Sunyi YeDepartment of Urology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Xiangping ZhangShenzhen Edge Medical Co, Shenzhen, China xzhang@foxmail.com.
Jianle MaoShenzhen Edge Medical Co, Shenzhen, China.
Yi ZhuDepartment of Urology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Honglei WangDepartment of Urology, Harbin Medical University Cancer Hospital, Harbin, China.
Shuangyu MaDepartment of Urology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
Cheng YangDepartment of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Weijun FuDepartment of Urology, Chinese PLA General Hospital, Beijing, China.
Tao SongDepartment of Urology, Chinese PLA General Hospital, Beijing, China.
Qing AiDepartment of Urology, Chinese PLA General Hospital, Beijing, China.
Yong SongDepartment of Urology, Chinese PLA General Hospital, Beijing, China.
Longhe XuDepartment of Anesthesiology, The Third Center of Chinese PLA General Hospital, Beijing, China.
Guoqiang YangDepartment of Urology, Chinese PLA General Hospital, Beijing, China.
Yu GaoDepartment of Urology, Chinese PLA General Hospital, Beijing, China.
Shaoxi NiuDepartment of Urology, Chinese PLA General Hospital, Beijing, China.
Jing GuoDepartment of Urology, Chinese PLA General Hospital, Beijing, China.
Guojun LiuDepartment of Urology, Chinese PLA General Hospital, Beijing, China.
Xueyuan XiangDepartment of Urology, Chinese PLA General Hospital, Beijing, China.
Chaozhao LiangDepartment of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Xin MaDepartment of Urology, Chinese PLA General Hospital, Beijing, China.
Hongzhao LiDepartment of Urology, Chinese PLA General Hospital, Beijing, China.
Xu ZhangDepartment of Urology, Chinese PLA General Hospital, Beijing, China xzhang@foxmail.com.ORCID https://orcid.org/0000-0002-0608-6509
TeleS Research Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate whether the reliability of telesurgery is non-inferior to that of standard local surgery in patients undergoing urological robotic operations.

designMulticentre, non-inferiority, randomised controlled trial.

settingFive hospitals in China from December 2023 to June 2024.

participantsPatients scheduled to undergo radical prostatectomy or partial nephrectomy.

interventionsPatients were randomly assigned 1:1 to undergo telesurgery or local surgery.

main outcome measuresThe primary outcome was the probability of success of surgery, determined by the medical team on the basis of pre-established criteria. The pre-specified non-inferiority margin was an absolute reduction in probability of 0.1. Thirteen clinical secondary outcomes were associated with the operation and early recovery, and one secondary outcome related to the workload of the medical team. Four technical secondary outcomes for the surgical system were also explored, including network latency, display latency, frame loss during telesurgery, and system malfunction. The participants were followed up at four and six weeks postoperatively for the secondary outcomes of recovery and complications.

resultsA total of 72 participants were enrolled in the study and randomised 1:1 to the telesurgery group and the local surgery group for the intention-to-treat set. The median age of patients was 61.0 (interquartile range 57.5-68.0) years in the telesurgery group and 65.0 (56.5-70.0) years in the local surgery group. Telesurgery was not inferior to local surgery in terms of the probability of surgical success in the intention-to-treat population, accounting for clustering by surgeon (success probability difference 0.02 (95% credible interval -0.03 to 0.15) with bayesian posterior probability of 0.99 for non-inferiority). The telesurgery system was stable with a distance from 1000 km to 2800 km, a mean round trip network latency of 20.1-47.5 ms, and frame loss of 0-1.5 per telesurgery. Secondary outcomes, including operative basic data, complications, early recovery, oncological outcome, and medical team workload, did not differ substantially between the two groups.

conclusionsThe reliability of telesurgery was non-inferior to that of local robotic surgery according to the non-inferiority margin of a 0.1 reduction in success probability.

trial registrationChiCTR.org ChiCTR2300077721.

Indexed as

NephrectomyProstatectomyRobotic Surgical ProceduresTelemedicineAgedChinaFemaleHumansMaleMiddle AgedPostoperative ComplicationsReproducibility of ResultsTreatment Outcome

Identifiers

PMID41605542
PMCPMC12849050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.